Softbank G: Acquired Roche shares: worth $ 5 billion
August 4, 2021 7:00 JST
SoftBank Group:
It secretly acquired a $ 5 billion stake in Roche Holding of Switzerland.
It became clear from the stories of several people familiar with the situation.
We are betting on Roche’s strategy to use data for drug development.
One of Roche’s largest shareholders:
It was analyzed with the aggregated data of Bloomberg.
SoftBank Group is now one of Roche’s largest shareholders.
Roche Sales:
Recently, it has been boosted in the antibody test reagent business for the new coronavirus.
The Roche Diagnostics division was one of the first to respond to the Corona pandemic.
Pharmaceuticals:
Traditional cancer treatments are facing more fierce competition.
Roche Stock Price:
Up 8.8% in the past year.
During the same period, the MSCI World Pharma Biotechnology and Life Sciences Index rose 14.7%.
Roche shares:
There are two types of voting shares and non-voting shares.
Founder is 50.1% of voting shares,
Swiss Novartis, one-third of voting shares,
Both own it.
It is unknown which type SoftBank Group acquired.
Softbank G concept:
SoftBank Group believes Roche’s Genentech division is significantly undervalued.
Invested by SoftBank G:
Further focus on the fields of biotechnology and healthcare.
So far
Pacific Biosciences of California,
Abcellera Biologics,
Invested in Sana Biotechnology.
Bloomberg
https://www.bloomberg.co.jp/news/articles/2021-08-03/QXA5F4DWX2Q001
SoftBank Is Said to Build $5 Billion Stake in Roche
Aug. 4, 2021, 4:18 PM
Japanese firm’s stake makes it one of Roche’s top investors
SoftBank believes Roche’s Genentech division is undervalued
SoftBank Group Corp.
has quietly built a $5 billion stake in Roche Holding AG, placing a bet on the pharmaceutical company’s strategy of using data to develop drugs, according to people familiar with the matter.The Japanese conglomerate is now one of Roche’s largest investors, according to data compiled by Bloomberg.